Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × artenimol × Clear all
NCT06417099 2025-04-23

Efficacy of Dihydroartemisinin for Treating PCOS

Shanghai Zhongshan Hospital

Phase 2 Completed
30 enrolled

Polycystic Ovary Syndrome

NCT06842524 2025-04-20

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Shanghai Zhongshan Hospital

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT05465135 2024-05-17

The Effect of Dihydroartemisinin in PCOS

Shanghai Zhongshan Hospital

Phase 4 Completed
19 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡